United States Hemato-Oncology Testing Market Set for Explosive Growth Amid Rising Cancer Diagnostics Demand 2025 | Major key players - Abbott Laboratories, Qiagen N.V., Archerdx, Inc.

Market Size and Growth:

The Global Hemato Oncology Testing Market size reached USD 280 million in 2022 and is projected to witness lucrative growth by reaching up to USD 620 million by 2030. The market is growing at a CAGR of 4.8% during the forecast period (2024-2031).

The Hemato Oncology Testing Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/hemato-oncology-testing-market?sz

The Hemato-Oncology Testing Market involves diagnostic tests and technologies used to detect, monitor, and manage blood cancers and related hematologic disorders. It includes tests such as flow cytometry, molecular profiling, cytogenetics, and immunoassays, aiding in early diagnosis, treatment planning, and prognosis assessment. Rising cancer prevalence and advanced testing solutions drive market growth globally.

Recent Key Developments of United States (U.S):

Accelerated FDA Approval for Multiple Myeloma Therapy: In July 2025, the FDA granted accelerated approval to linvoseltamab-gcpt (Lynozyfic), a bispecific antibody for treating adults with relapsed or refractory multiple myeloma who have received at least four prior therapies.

Expanded Oncology Portfolio from Labcorp: In May 2025 (though announced just outside the 3-month window, its impact is recent), Labcorp announced an expansion of its precision oncology portfolio, adding new Next-Generation Sequencing (NGS) panels for myeloid, lymphoid, and pan-heme indications to provide broader genomic coverage for patients with hematologic malignancies.

Focus on Artificial Intelligence (AI) and Digital Pathology: Throughout 2025, there has been a significant trend in the integration of AI with digital pathology to enhance diagnostic accuracy, streamline workflows, and enable more precise and personalized treatment strategies for blood cancers.

New FDA Approval for Follicular Lymphoma: In June 2025, the FDA approved tafasitamab-cxix (Monjuvi) in combination with lenalidomide and rituximab for adults with relapsed or refractory follicular lymphoma.

FDA Approval of a New Blood Cancer Drug: In August 2025, the FDA granted accelerated approval to dordaviprone (Modeyso) for adult and pediatric patients with diffuse midline glioma, a type of brain cancer that can be considered within the broader scope of hemato-oncology due to its effect on the central nervous system.

List of the Key Players in the Hemato Oncology Testing Market:

F. Hoffman-La Roche Ltd.
Abbott Laboratories
Qiagen N.V.
Thermo Fisher Scientific, Inc.
Illumina, Inc.
Bio-Rad Laboratories, Inc.
ICON PLC
Archerdx, Inc.
Invivoscribe, Inc.
Adaptive Biotechnologies.

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=hemato-oncology-testing-market

Segments Covered in the Hemato Oncology Testing Market:

By Type of Product & Service: Instruments, Reagents & Consumables, Services.

By Technology: PCR (Polymerase Chain Reaction), IHC (immunohistochemical), NGS (Next-Generation Sequencing), Cytogenetics, Others.

By Cancer Type: Leukemia, Lymphoma, Multiple myelomas, Others.

By End-User: Clinical Laboratories, Hospitals, Academic: Research Institutes, Others.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/hemato-oncology-testing-market?sz

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Hemato Oncology Testing market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Hemato Oncology Testing Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The Global Hemato Oncology Testing market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Hemato Oncology Testing Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Hemato Oncology Testing Market in 2025?
◆ What is the projected growth rate of the Hemato Oncology Testing Market through 2033?
◆ Who are the key players in the Hemato Oncology Testing Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.